Your account is not claimed yet. You can sign up with ORCID to claim your account.

Remi Adelaiye-Ogala

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Binding Protein

Prostate Cancer

Radical Prostatectomy

Top Venues

Molecular cancer therapeutics

National Cancer Institute

University at Buffalo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute

United States

Post Doctoral Fellow

Education History

University at Buffalo

United States

PHD :: Cancer Pathology & Prevention, Roswell Park Cancer Institute Division

Publications

Lynda Bennett, Praveen Kumar Jaiswal, Ryan V Harkless, Tiha M Long, Ning Gao, Brianna Vandenburg, Phillip Selman, Ishrat Durdana, Ricardo R Lastra, Donald J Vander Griend, Remi Adelaiye-Ogala, Russell Z Szmulewitz, Suzanne D Conzen
Glucocorticoid receptor (GR) activation is associated with increased cAMP/PKA signaling in castrate-resistant prostate cancer. Molecular cancer therapeutics (2023)
Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, Jeremie Calais, Lucia Nappi, Ravi B Parikh, Tyler M Seibert, Elizabeth V Wasmuth, Xiao X Wei, Kenneth J Pienta, Howard R Soule
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting. The Prostate (2022)
Remi Adelaiye-Ogala, Berkley E Gryder, Yen Thi Minh Nguyen, Aian Neil Alilin, Adlai R Grayson, Wardah Bajwa, Keith H Jansson, Michael L Beshiri, Supreet Agarwal, Jose Antonio Rodriguez-Nieves, Brian Capaldo, Kathleen Kelly, David J VanderWeele
Targeting the PI3K/AKT Pathway Overcomes Enzalutamide Resistance by Inhibiting Induction of the Glucocorticoid Receptor. Molecular cancer therapeutics 19 (7) (2020)